Publications:

Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing.

Frontiers In Oncology

Sun, Dantong D; Yan, Weihua W; Zhu, Hua H; Liu, Qiaoling Q; Hou, Helei H

Publication Date: 2020

Variant appearance in text: NOTCH1: C359Y

PubMed Link: 33194681

Variant Present in the following documents:

• Main text

View BVdb publication page

Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma.

Cancer Biology & Therapy

Sun, Dantong D; Liu, Dong D; Liu, Qiaoling Q; Hou, Helei H

Publication Date: 2020-12-01

Variant appearance in text: NOTCH1: C359Y

PubMed Link: 33151119

Variant Present in the following documents:

• Main text
• KCBT_21_1834319.pdf

View BVdb publication page